Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jul;62(1):23–27. doi: 10.1038/bjc.1990.222

Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting.

E M Boltz 1, P Harnett 1, J Leary 1, R Houghton 1, R F Kefford 1, M L Friedlander 1
PMCID: PMC1971745  PMID: 2390478

Abstract

A detailed study was performed in 14 patients with epithelial ovarian tumours using the satellite probes 33.15, 228S and 216S to investigate the nature of somatic changes and frequency with which clonal changes could be demonstrated during metastasis and progression. Somatic changes were evident in approximately 70% of ovarian tumours, the most common being a deletion or reduction in intensity of a band suggesting loss of heterozygosity. Additional changes that were observed included increased intensification of single bands and the appearance of novel DNA fragments. Somatic alterations were seen following digestion of DNA with methylation resistant restriction endonucleases indicating that methylation differences alone could not account for all of the somatic changes. Using DNA fingerprint analysis ovarian tumours were shown to be heterogeneous with different DNA patterns observed in different sites in five of eight patients. Generally, within an individual patient the primary and metastases appeared to share a DNA fingerprint pattern with minor variations occurring in different sites suggesting that different populations have derived from a common stem line. This study clearly demonstrates that DNA fingerprint analysis is a sensitive method to detect somatic changes in tumour DNA and for investigating the development of clonal heterogeneity in ovarian tumours.

Full text

PDF
23

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boltz E. M., Kefford R. F., Leary J. A., Houghton C. R., Friedlander M. L. Amplification of c-ras-Ki oncogene in human ovarian tumours. Int J Cancer. 1989 Mar 15;43(3):428–430. doi: 10.1002/ijc.2910430314. [DOI] [PubMed] [Google Scholar]
  2. Fey M. F., Wells R. A., Wainscoat J. S., Thein S. L. Assessment of clonality in gastrointestinal cancer by DNA fingerprinting. J Clin Invest. 1988 Nov;82(5):1532–1537. doi: 10.1172/JCI113762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fowler C., Drinkwater R., Skinner J., Burgoyne L. Human satellite-III DNA: an example of a "macrosatellite" polymorphism. Hum Genet. 1988 Jul;79(3):265–272. doi: 10.1007/BF00366249. [DOI] [PubMed] [Google Scholar]
  4. Friedlander M. L., Hedley D. W., Swanson C., Russell P. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. J Clin Oncol. 1988 Feb;6(2):282–290. doi: 10.1200/JCO.1988.6.2.282. [DOI] [PubMed] [Google Scholar]
  5. Friedlander M. L., Hedley D. W., Taylor I. W. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol. 1984 Sep;37(9):961–974. doi: 10.1136/jcp.37.9.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frost P., Kerbel R. S. On a possible epigenetic mechanism(s) of tumor cell heterogeneity. The role of DNA methylation. Cancer Metastasis Rev. 1983;2(4):375–378. doi: 10.1007/BF00048568. [DOI] [PubMed] [Google Scholar]
  7. Jakobsen A., Nielsen K. V., Rønne M. DNA distribution and chromosome number in human cervical carcinoma. Anal Quant Cytol. 1983 Mar;5(1):13–18. [PubMed] [Google Scholar]
  8. Jeffreys A. J., Wilson V., Thein S. L. Hypervariable 'minisatellite' regions in human DNA. Nature. 1985 Mar 7;314(6006):67–73. doi: 10.1038/314067a0. [DOI] [PubMed] [Google Scholar]
  9. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
  10. Ponder B. Cancer. Gene losses in human tumours. Nature. 1988 Sep 29;335(6189):400–402. doi: 10.1038/335400a0. [DOI] [PubMed] [Google Scholar]
  11. Razin A., Riggs A. D. DNA methylation and gene function. Science. 1980 Nov 7;210(4470):604–610. doi: 10.1126/science.6254144. [DOI] [PubMed] [Google Scholar]
  12. Sutherland C., Shaw H. M., Roberts C., Grace J., Stewart M. M., McCarthy W. H., Kefford R. F. Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds. Br J Cancer. 1986 Nov;54(5):787–790. doi: 10.1038/bjc.1986.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Thein S. L., Jeffreys A. J., Gooi H. C., Cotter F., Flint J., O'Connor N. T., Weatherall D. J., Wainscoat J. S. Detection of somatic changes in human cancer DNA by DNA fingerprint analysis. Br J Cancer. 1987 Apr;55(4):353–356. doi: 10.1038/bjc.1987.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thein S. L., Oscier D. G., Jeffreys A. J., Hesketh C., Pilkington S., Summers C., Fitchett M., Wainscoat J. S. Detection of chromosomal 7 loss in myelodysplasia using an extremely polymorphic DNA probe. Br J Cancer. 1988 Feb;57(2):131–134. doi: 10.1038/bjc.1988.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wake N., Hreshchyshyn M. M., Piver S. M., Matsui S., Sandberg A. A. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res. 1980 Dec;40(12):4512–4518. [PubMed] [Google Scholar]
  16. Wong Z., Wilson V., Jeffreys A. J., Thein S. L. Cloning a selected fragment from a human DNA 'fingerprint': isolation of an extremely polymorphic minisatellite. Nucleic Acids Res. 1986 Jun 11;14(11):4605–4616. doi: 10.1093/nar/14.11.4605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Woodruff J. D., Julian C. G. Multiple malignancy in the upper genital canal. Am J Obstet Gynecol. 1969 Mar 15;103(6):810–822. doi: 10.1016/0002-9378(69)90579-1. [DOI] [PubMed] [Google Scholar]
  18. de Jong D., Voetdijk B. M., Kluin-Nelemans J. C., van Ommen G. J., Kluin P. M. Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting. Br J Cancer. 1988 Dec;58(6):773–775. doi: 10.1038/bjc.1988.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. van 't Veer L. J., Hermens R., van den Berg-Bakker L. A., Cheng N. C., Fleuren G. J., Bos J. L., Cleton F. J., Schrier P. I. ras oncogene activation in human ovarian carcinoma. Oncogene. 1988 Feb;2(2):157–165. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES